Pulmonary tumor thrombotic microangiopathy of hepatocellular carcinoma: A case report and review of literature

Table 1 Laboratory examination

Hematology		Biochemistry		Marker
WBC	4840/μL	TP	8.0 g/dL	HBs Ag	-
Neutro	70.5 %	Alb	3.4 g/dL	Anti-HBs	-
Lymp	16.9 %	BUN	14 mg/dL	Anti-HBc	-
Eos.	3.7 %	Cre	0.59 mg/dL	Anti-HCV	-
Bas.	0.4 %	T-Bil	1.0 mg/dL
Mon.	8.5 %	D-Bil	0.2 mg/dL	AFP	67183 ng/mL
RBC	392 × 104 /μL	AST	74 IU/L	AFP-L3	37.2 %
Hb	12.4 g/dL	ALT	31 IU/L	PIVKA-II	> 75000 mAU/mL
Ht.	35.9 %	ALP	828 IU/L	KL-6	300 IU/mL
Plt.	8.0 × 104 /μL	LDH	432 IU/L	SP-D	87.6 ng/mL
		γ-GTP	737 IU/L
		ChE	165 IU/L
		NH3	92 μL/dL
		Na	130 mEq/L	Blood Gas Analysis of 6th day (O2 2L)
		K	3.8 mEq/L	SpO2	91%
		Cl	100 mEq/L	pH	7.456
Coagulation		P	3.3 mg/dL	pCO2	35.2 mmHg
PT%	76 %	Ca	9.0 mg/dL	pO2	62.9 mmHg
PT-INR	1.15	CRP	5.37 mg/dL	HCO3	24.3 mmol/L
APTT	36.3 sec	FBS	103 mg/dL	BE	0.7 mmol/L
		HbA1c	5.5 %
		TG	58 mg/dL
		HDL-C	50 mg/dL
		LDL-C	138 mg/dL

PT: Prothrombin time activity; APTT: Activated partial thromboplastin time; BUN: Blood urea nitrogen; Cre: Creatinine; T-Bil: Total bilirubin; D-Bil: Direct bilirubin; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; ALP: Alkaline phosphatase; LDH: Lactate dehydrogenase; γ-GTP: γ-glutamyltransferase; ChE: Cholinesterase; NH3: Ammonia; CRP: C-reactive protein; FBS: Fasting blood sugar; HbA1c: Hemoglobin A1c; TG: Triglyceride; HDL-C: High density lipoprotein; LDL-C: Low density lipoprotein; AFP: α-fetoprotein; PIVKA-II: Protein induced by vitamin K absence or antagonist II; KL-6: Sialylated carbohydrate antigen; SP-D: Surfactant Protein-D; SpO₂: Percutaneous oxygen saturation; BE: Base excess; HCV: Hepatitis C virus.